Ash Stevens, INC. Invests In Riverview Facility

ASI installed a new Bruker Biospin 400 MHz Avance III nuclear magnetic resonance (NMR) instrument as well as a third Rosenmund filter-dryer. The NMR will enable the company's chemists to rapidly obtain detailed analytical and structural information. The filter-dryer will be equipped with glove-box technology for handling potent and air sensitive cGMP APIs in a contained environment.

Detroit, MI (PRWEB) February 8, 2008 -- Ash Stevens Inc.™ (ASI), a developer of high quality, small-molecule Active Pharmaceutical Ingredients (APIs), upgraded its Riverview, Mich. manufacturing facility with new state-of-the-art equipment.

ASI installed a new Bruker Biospin 400 MHz Avance III nuclear magnetic resonance (NMR) instrument. Equipped with a dual proton/carbon-13 probe, the NMR will enable the company's chemists to rapidly obtain detailed analytical and structural information. In addition, ASI will place its third Rosenmund filter-dryer online in 2008. The filter-dryer will be equipped with glove-box technology for handling potent and air sensitive cGMP APIs in a contained environment.

"These investments in our Riverview facility will help us maintain our high standards and satisfy increasingly robust manufacturing demand," said Dr. Stephen Munk, President and CEO, ASI. "With more than 45 years of experience and 11 FDA approvals to manufacture innovator APIs, Ash Stevens has earned a reputation as the premier provider of quality contract pharmaceutical manufacturing services for specialized APIs."

Headquartered in Detroit, Ash Stevens was founded in 1962 to service the chemical research needs of the federal government. The company has since expanded in scope, becoming a leading chemical research organization and provider of specialized APIs to both the federal government and the commercial pharmaceutical industry. Today, ASI has expertise in high potency compounds and holds a variety of patents in medicinal and process chemistry. The company maintains research laboratories in Detroit and a state-of-the art, cGMP compliant manufacturing plant in Riverview, Mich. with total reactor capacity of 1,500 gallons.

About Ash Stevens, Inc.
Headquartered in Detroit, Ash Stevens, Inc. (ASI) was founded in 1962 to service the chemical research needs of the Federal Government. ASI has a total of 11 FDA approved drug substances in its portfolio. The company has more than 50 employees and holds patents in both medicinal and process chemistry. For more information, visit www.ashstevens.com.

###